In fact, when summarizing the study in Table 4 it was evident that DC:TC co-cultures were superior to conventional PBMC cultures in detecting CD4+ T cell peptide recognition and only in one MG patient (MG4) did we detect a response that was of comparable range in the two assay systems (Table 4). The gene discussed is CD4; the disease is myasthenia gravis.